News

Stay connected – Follow our latest updates and meet our team!

September 3, 2025

Join Mabqi at the Festival of Biologics – Choose France Pavillion booth #8

September 1, 2025

Mabqi at AI4Immuno-Oncology: Advancing Cancer Care Through AI

August 25, 2025

Mabqi has joined PSCC Connect

June 5, 2025

Mabqi welcomes Prof. Jean-Yves Blay as Medical Advisor

May 20, 2025

Visit Mabqi at Booth #40 during the 13th Antibody Industrial Symposium (AIS)

May 15, 2025

Mabqi to Attend 2025 BIO International Convention in Boston

May 13, 2025

Mabqi to Attend Antibody Engineering & Therapeutics Europe 2025

April 30, 2025

Mabqi to Attend BioEquity Europe 2025

April 15, 2025

Mabqi welcomes Prof. Karim Fizazi as Medical Advisor

« Previous Page1 Page2 Page3 Page4 Next »

Mabqi is a biotechnology company focused on the discovery and development of fully human antibodies. Leveraging an innovative platform, we specialize in uncovering monoclonal antibodies (mAbs), antibody-drug conjugates (ADCs), pH-sensitive antibodies, and various other immunotherapy formats.

Legal notice